152 related articles for article (PubMed ID: 32533834)
1. Endothelium-restricted endothelin-1 overexpression in type 1 diabetes worsens atherosclerosis and immune cell infiltration via NOX1.
Ouerd S; Idris-Khodja N; Trindade M; Ferreira NS; Berillo O; Coelho SC; Neves MF; Jandeleit-Dahm KA; Paradis P; Schiffrin EL
Cardiovasc Res; 2021 Mar; 117(4):1144-1153. PubMed ID: 32533834
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of NOX4 and NOX1 on immune cell-mediated inflammation in the aortic sinus of diabetic ApoE-/- mice.
Di Marco E; Gray SP; Chew P; Kennedy K; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Clin Sci (Lond); 2016 Aug; 130(15):1363-74. PubMed ID: 27190136
[TBL] [Abstract][Full Text] [Related]
4. Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.
Gray SP; Di Marco E; Kennedy K; Chew P; Okabe J; El-Osta A; Calkin AC; Biessen EA; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):295-307. PubMed ID: 26715682
[TBL] [Abstract][Full Text] [Related]
5. NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis.
Di Marco E; Gray SP; Kennedy K; Szyndralewiez C; Lyle AN; Lassègue B; Griendling KK; Cooper ME; Schmidt HHHW; Jandeleit-Dahm KAM
Free Radic Biol Med; 2016 Aug; 97():556-567. PubMed ID: 27445103
[TBL] [Abstract][Full Text] [Related]
6. Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-/- mice with or without diabetes.
Hanssen NM; Brouwers O; Gijbels MJ; Wouters K; Wijnands E; Cleutjens JP; De Mey JG; Miyata T; Biessen EA; Stehouwer CD; Schalkwijk CG
Cardiovasc Res; 2014 Oct; 104(1):160-70. PubMed ID: 25139743
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis.
Gray SP; Di Marco E; Okabe J; Szyndralewiez C; Heitz F; Montezano AC; de Haan JB; Koulis C; El-Osta A; Andrews KL; Chin-Dusting JP; Touyz RM; Wingler K; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Circulation; 2013 May; 127(18):1888-902. PubMed ID: 23564668
[TBL] [Abstract][Full Text] [Related]
8. PKC-Mediated Endothelin-1 Expression in Endothelial Cell Promotes Macrophage Activation in Atherogenesis.
Zhang J; Wang YJ; Wang X; Xu L; Yang XC; Zhao WS
Am J Hypertens; 2019 Aug; 32(9):880-889. PubMed ID: 31111864
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of vascular NADPH oxidase expression and reactive oxygen species production by histone deacetylase-dependent mechanisms in experimental diabetes.
Manea SA; Antonescu ML; Fenyo IM; Raicu M; Simionescu M; Manea A
Redox Biol; 2018 Jun; 16():332-343. PubMed ID: 29587244
[TBL] [Abstract][Full Text] [Related]
10. Preservation of endothelium-dependent relaxation in atherosclerotic mice with endothelium-restricted endothelin-1 overexpression.
Mian MO; Idris-Khodja N; Li MW; Leibowitz A; Paradis P; Rautureau Y; Schiffrin EL
J Pharmacol Exp Ther; 2013 Oct; 347(1):30-7. PubMed ID: 23902937
[TBL] [Abstract][Full Text] [Related]
11. Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques.
Xu S; Chamseddine AH; Carrell S; Miller FJ
Redox Biol; 2014; 2():642-50. PubMed ID: 24936437
[TBL] [Abstract][Full Text] [Related]
12. Endothelial NADPH oxidase 4 protects ApoE-/- mice from atherosclerotic lesions.
Craige SM; Kant S; Reif M; Chen K; Pei Y; Angoff R; Sugamura K; Fitzgibbons T; Keaney JF
Free Radic Biol Med; 2015 Dec; 89():1-7. PubMed ID: 26169727
[TBL] [Abstract][Full Text] [Related]
13. Nox1/4 inhibition exacerbates age dependent perivascular inflammation and fibrosis in a model of spontaneous hypertension.
Nosalski R; Mikolajczyk T; Siedlinski M; Saju B; Koziol J; Maffia P; Guzik TJ
Pharmacol Res; 2020 Nov; 161():105235. PubMed ID: 33131726
[TBL] [Abstract][Full Text] [Related]
14. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.
Lewis P; Stefanovic N; Pete J; Calkin AC; Giunti S; Thallas-Bonke V; Jandeleit-Dahm KA; Allen TJ; Kola I; Cooper ME; de Haan JB
Circulation; 2007 Apr; 115(16):2178-87. PubMed ID: 17420349
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.
Manea SA; Vlad ML; Fenyo IM; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
Redox Biol; 2020 Jan; 28():101338. PubMed ID: 31634818
[TBL] [Abstract][Full Text] [Related]
16. Attenuated Superoxide Dismutase 2 Activity Induces Atherosclerotic Plaque Instability During Aging in Hyperlipidemic Mice.
Vendrov AE; Stevenson MD; Alahari S; Pan H; Wickline SA; Madamanchi NR; Runge MS
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079564
[TBL] [Abstract][Full Text] [Related]
17. Reduced macrophage-dependent inflammation improves endothelin-1-induced vascular injury.
Javeshghani D; Barhoumi T; Idris-Khodja N; Paradis P; Schiffrin EL
Hypertension; 2013 Jul; 62(1):112-7. PubMed ID: 23670300
[TBL] [Abstract][Full Text] [Related]
18. Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy.
Deliyanti D; Alrashdi SF; Touyz RM; Kennedy CR; Jha JC; Cooper ME; Jandeleit-Dahm KA; Wilkinson-Berka JL
Hypertension; 2020 Apr; 75(4):1091-1101. PubMed ID: 32114846
[TBL] [Abstract][Full Text] [Related]
19. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
Jha JC; Gray SP; Barit D; Okabe J; El-Osta A; Namikoshi T; Thallas-Bonke V; Wingler K; Szyndralewiez C; Heitz F; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
J Am Soc Nephrol; 2014 Jun; 25(6):1237-54. PubMed ID: 24511132
[TBL] [Abstract][Full Text] [Related]
20. Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice.
Buday A; Orsy P; Godó M; Mózes M; Kökény G; Lacza Z; Koller A; Ungvári Z; Gross ML; Benyó Z; Hamar P
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H386-95. PubMed ID: 20511416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
